VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
TECHBuyZACKSHold
R500#170 today
$17.60
+0.80% today · -1.29% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- VTRS +0.80% on the last session vs SPY +0.74%: +0.1 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 64 big drops in the past 5 years, VTRS typically gained 1.1% over the next week (median) and was higher 66% of the time; half the outcomes fell between -1.2% and +4.5%. An ordinary week: +0.3%. Among S&P 500 stocks after big drops, that ranks #58 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 5
Before the open · in 32 days
EPS estimate
$0.64
$0.61 to $0.69 · 10 analysts
Revenue estimate
$3.8B
$3.7B to $3.9B
Track record
7/8 beats
last 8 reports · moved ±8.7% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 BMO | 2Q2026 | $0.60 | $0.69 | +$0.09 (+15.0%) beat | $3.8B | -7.7% -7.5 vs SPY | +2.8% | -8.8% |
| May 7, 2026 BMO | 1Q2026 | $0.50 | $0.59 | +$0.09 (+17.5%) beat | $3.5B | +9.0% +9.3 vs SPY | +5.2% | +8.9% |
| Feb 26, 2026 BMO | 4Q2025 | $0.53 | $0.57 | +$0.04 (+7.4%) beat | $3.7B | -5.2% -4.6 vs SPY | +0.1% | -8.5% |
| Nov 6, 2025 BMO | 3Q2025 | $0.62 | $0.67 | +$0.05 (+8.5%) beat | $3.8B | -6.0% -4.9 vs SPY | -1.6% | +2.4% |
| Aug 7, 2025 BMO | $0.56 | $0.62 | +$0.06 (+10.7%) beat | — | +7.3% +7.4 vs SPY | +2.9% | +19.0% | |
| May 8, 2025 BMO | $0.49 | $0.50 | +$0.01 (+2.0%) beat | — | +5.7% +5.0 vs SPY | +4.7% | -2.1% | |
| Feb 27, 2025 BMO | $0.57 | $0.54 | −$0.03 (−5.3%) miss | — | -15.2% -13.6 vs SPY | -17.6% | -15.7% | |
| Nov 7, 2024 BMO | $0.68 | $0.75 | +$0.07 (+10.3%) beat | — | +13.5% +12.8 vs SPY | +1.7% | +12.0% | |
| Aug 8, 2024 BMO | $0.68 | $0.69 | +$0.01 (+1.5%) beat | — | +6.5% +4.2 vs SPY | +4.6% | +0.3% | |
| May 9, 2024 BMO | $0.67 | $0.67 | $0.00 (0.0%) in line | — | -5.0% -5.6 vs SPY | -3.2% | -6.3% | |
| Feb 28, 2024 BMO | $0.65 | $0.62 | −$0.03 (−4.6%) miss | — | -7.1% -7.0 vs SPY | -0.1% | -7.2% | |
| Nov 7, 2023 AMC | $0.74 | $0.79 | +$0.05 (+6.8%) beat | — | +1.0% +0.9 vs SPY | +4.0% | +1.0% | |
| Aug 7, 2023 BMO | $0.71 | $0.75 | +$0.04 (+5.6%) beat | — | +3.9% +3.0 vs SPY | +2.5% | +7.2% | |
| May 8, 2023 BMO | $0.70 | $0.77 | +$0.07 (+10.0%) beat | — | +5.8% +5.8 vs SPY | +3.5% | 0.0% | |
| Feb 27, 2023 BMO | $0.72 | $0.67 | −$0.05 (−6.9%) miss | — | -2.7% -3.0 vs SPY | -1.1% | -3.3% | |
| Nov 7, 2022 BMO | $0.84 | $0.87 | +$0.03 (+3.6%) beat | — | +13.1% +12.1 vs SPY | +6.6% | +17.9% | |
| Aug 8, 2022 BMO | $0.82 | $0.88 | +$0.06 (+7.3%) beat | — | +3.7% +3.8 vs SPY | +4.6% | +14.4% | |
| May 9, 2022 BMO | $0.83 | $0.93 | +$0.10 (+12.0%) beat | — | +5.3% +8.5 vs SPY | +1.8% | +11.4% | |
| Feb 28, 2022 BMO | $0.83 | $0.80 | −$0.03 (−3.6%) miss | — | -24.3% -24.0 vs SPY | -5.6% | -29.9% | |
| Nov 8, 2021 BMO | $0.88 | $0.99 | +$0.11 (+12.5%) beat | — | +6.9% +6.8 vs SPY | +5.0% | +2.8% | |
| Aug 9, 2021 BMO | $0.88 | $0.98 | +$0.10 (+11.4%) beat | — | — | — | — | |
| May 10, 2021 BMO | $0.80 | $0.92 | +$0.12 (+15.0%) beat | — | — | — | — | |
| Mar 1, 2021 AMC | $1.24 | $0.62 | −$0.62 (−50.0%) miss | — | — | — | — | |
| Nov 6, 2020 BMO | $1.16 | $1.31 | +$0.15 (+12.9%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $0.64 (10) | $0.61 – $0.69 | -4% | -0.8% | ▲0 ▼2 | $3.8B | +1% |
| Next quarter · Dec 31, 2026 | $0.59 (10) | $0.55 – $0.64 | +4% | -5.4% | ▲0 ▼2 | $3.7B | 0% |
| Current year · Dec 31, 2026 | $2.52 (11) | $2.47 – $2.58 | +7% | +1.7% | ▲3 ▼0 | $14.8B | +3% |
| Next year · Dec 31, 2027 | $2.67 (11) | $2.59 – $2.80 | +6% | +0.3% | ▲3 ▼3 | $15.0B | +2% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.